ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,139 | -12.9% | 69 | -17.9% | 0.00% | – |
| Q3 2022 | $30,000 | -98.2% | 84 | -98.0% | 0.00% | -100.0% |
| Q2 2022 | $1,628,000 | +20.0% | 4,297 | -0.2% | 0.01% | +42.9% |
| Q1 2022 | $1,357,000 | -8.0% | 4,304 | +2.2% | 0.01% | 0.0% |
| Q4 2021 | $1,475,000 | +16.0% | 4,213 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,272,000 | +0.3% | 4,213 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,268,000 | +14.0% | 4,213 | +4.4% | 0.01% | 0.0% |
| Q1 2021 | $1,112,000 | -6.3% | 4,037 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,187,000 | +37.4% | 4,037 | +22.7% | 0.01% | +16.7% |
| Q3 2020 | $864,000 | +16.6% | 3,291 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $741,000 | +70.7% | 3,291 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $434,000 | -17.8% | 3,291 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $528,000 | – | 3,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |